Brinton L A, Gridley G, Persson I, Baron J, Bergqvist A
Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD 20892, USA.
Am J Obstet Gynecol. 1997 Mar;176(3):572-9. doi: 10.1016/s0002-9378(97)70550-7.
Our goal was to determine the risk of cancer after hospitalization for endometriosis.
Records of 20,686 women hospitalized with endometriosis during the period 1969 to 1983, as identified through the nationwide Swedish Inpatient Register, were linked against the National Swedish Cancer Registry through 1989 to identify all subsequent diagnoses of cancer. The study subjects were followed up for a mean of 11.4 years, with the cohort contributing 216,851 woman years of follow-up. Standardized incidence ratios were computed by the use of age- and period-specific incidence rates derived from the Swedish population. Because of the high proportion of subjects with gynecologic operations (55.6%), evaluation of the risk of gynecologic cancers involved truncation of person years at the time of any such operation.
The overall cancer risk was 1.2 (95% confidence interval 1.1 to 1.3). Significant excesses were observed for breast cancer (standardized incidence ratio = 1.3, 95% confidence interval 1.1 to 1.4), ovarian cancer (1.9, 1.3 to 2.8), and hematopoietic malignancies (1.4, 1.0 to 1.8); this latter excess was largely driven by an excess risk of non-Hodgkin's lymphoma (1.8, 1.2 to 2.6). The risk of ovarian cancer was particularly elevated among subjects with a long-standing history of ovarian endometriosis (4.2, 2.0 to 7.7). Cervical cancer risk was slightly reduced (0.7, 0.4 to 1.3) whereas no association was observed for cancer of the endometrium (1.1, 0.6 to 1.9).
These findings suggest that further attention be given to the risk of breast, ovarian and hematopoietic cancers among women with endometriosis and to exploring possible hormonal and immunologic reasons for the excess risks.
我们的目标是确定子宫内膜异位症住院治疗后患癌风险。
通过瑞典全国住院患者登记系统识别出的1969年至1983年期间因子宫内膜异位症住院的20686名女性的记录,与瑞典国家癌症登记系统进行关联,直至1989年,以确定所有后续癌症诊断情况。研究对象平均随访11.4年,该队列贡献了216851人年的随访数据。使用源自瑞典人群的年龄和时期特异性发病率计算标准化发病率比。由于接受妇科手术的受试者比例较高(55.6%),对妇科癌症风险的评估涉及在任何此类手术时截断人年数。
总体患癌风险为1.2(95%置信区间1.1至1.3)。乳腺癌(标准化发病率比 = 1.3,95%置信区间1.1至1.4)、卵巢癌(1.9,1.3至2.8)和造血系统恶性肿瘤(1.4,1.0至1.8)的风险显著增加;后者的增加主要由非霍奇金淋巴瘤的风险增加(1.8,1.2至2.6)驱动。在有长期卵巢子宫内膜异位症病史的受试者中,卵巢癌风险尤其升高(4.2,2.0至7.7)。宫颈癌风险略有降低(0.7,0.4至1.3),而子宫内膜癌未观察到关联(1.1,0.6至1.9)。
这些发现表明,应进一步关注子宫内膜异位症女性患乳腺癌、卵巢癌和造血系统癌症的风险,并探索风险增加的可能激素和免疫原因。